Andrea Howard, MD, MS

Director, Clinical & Training Unit

Dr. Andrea Howard is the director of the Clinical and Training Unit at ICAP, where she oversees the design and implementation of clinical, laboratory, and training programs for the prevention, care, and treatment of HIV, tuberculosis (TB), and related conditions in resource-limited settings in sub-Saharan Africa and Asia. She is currently leading two cluster-randomized trials aimed at defining best practices for integrating TB and HIV service delivery programs in sub-Saharan Africa: the NIH-funded ENRICH Study, which aims to evaluate the effectiveness of a combination intervention package versus standard of care to improve isoniazid preventive therapy (IPT) initiation, adherence and completion among HIV-infected individuals in Ethiopia; and the USAID-funded START Study, which aims to evaluate the effectiveness, cost-effectiveness and acceptability of a combination intervention package versus standard of care to improve early initiation of antiretroviral treatment (ART) and retention during TB treatment, as well as TB treatment success, among HIV-infected TB patients in Lesotho, and build in-country research capacity. In addition, she has been a co-investigator on several NIH and CDC-funded HIV cohort studies in women and drug users, including the Women’s Interagency HIV Study (WIHS), the HIV Epidemiology Research Study (HERS), and the Bronx HIV Epidemiologic Research on Outcomes (HERO) Study. Dr. Howard is an associate professor of epidemiology at Columbia University and director of the Global HIV Implementation Science Research Training Fellowship at the Mailman School of Public Health.